-->

Extended Today Only

Post a Comment
Zacks | Our Research. Your Success.

First Headline Stocks Post Tomorrow

Zacks Member,

I'm Daniel Laboe, director of our Headline Trader portfolio.

Zacks Executive Vice President Kevin Matras has authorized me to extend your invitation for one final day to take part in our new trading strategy.

Tomorrow morning after the market opens, I'll post the portfolio's first 3 stocks. This means you can get in on them from the very beginning while their profit potential is greatest.

One of the companies is manufacturing critical tech parts that are currently under supply.

The second recommendation is based on reports of a restructuring that most investors are not yet aware of.

The third pick won't be targeted until the last minute as the initial flow of trading is analyzed.

Right now I'm seeing an abundance of opportunity as folks get vaccinated, emerge from lockdown, and start spending their way to economic recovery. We could meet or even exceed gains from recent recommendations that I made based on emerging news: ¹

+224.3% from QuantumScape in 3 Months

+93.9% from Micro Strategy in 6 Weeks

+95.0% from Target in 16-1/2 Months

+219.4% from CRISPR in 1 Year

What's more, while our Headline Trader profit journey will mostly be in hot pursuit of positive intelligence, we can also go short to profit from stocks set to plummet.

Can't wait to get started and hope you'll be with us! Only $1 to catch all our buys and sells for 30 days and not a cent of further obligation.

There will be no further extensions so please be sure to get back to us before midnight Monday, February 15 - tonight.

Regards,

>Daniel Laboe
Daniel Laboe

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter